Viewpoint Capital Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$244K Buy
+203
New +$207K 0.12% 85
2026
Q1
Sell
-206
Closed -$221K 138
2025
Q4
$221K Buy
+206
New +$197K 0.1% 100

Other funds holding LLY

Viewpoint Capital Management's LLY Position: Q2 2026 in Review

Viewpoint Capital Management opened a new position in Eli Lilly (LLY) in Q2 2026: 203 shares worth $244K. The stake represents 0.12% of the portfolio and ranks #85 among its holdings. This is a return to the name: Viewpoint Capital Management previously reported a position in LLY as recently as Q4 2025.

Viewpoint Capital Management first reported a position in LLY in Q4 2025 and has held it in 2 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Viewpoint Capital Management held 203 shares of Eli Lilly worth $244K as of Q2 2026.
  • Eli Lilly was a new Viewpoint Capital Management position in Q2 2026.
  • Eli Lilly made up 0.12% of Viewpoint Capital Management's portfolio in Q2 2026, its #85 holding.
  • Viewpoint Capital Management first reported a position in Eli Lilly in Q4 2025 and has held it in 2 quarters since.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Viewpoint Capital Management's 13F filing for Q2 2026, filed 4 Aug 2026.